Status:
UNKNOWN
Prediction Model of CP-EBUS in the Diagnosis of Lymph Nodes
Lead Sponsor:
Shanghai Chest Hospital
Conditions:
Lymph Node Disease
Eligibility:
All Genders
18+ years
Brief Summary
Endobronchial ultrasound (EBUS) multimodal image including grey scale, blood flow doppler and elastography, can be used as non-invasive diagnosis and supplement the pathological result, which has impo...
Detailed Description
Intrathoracic LNs enlargement has a wide range of diseases, among which intrathoracic LNs metastasis of lung cancer is the most common malignant disease. Benign lesions, including inflammation, tuberc...
Eligibility Criteria
Inclusion
- Chest CT shows enlarged intrathoracic LNs (short diameter \> 1 cm) or PET / CT shows patients with increased FDG uptake (SUV ≧ 2.0) in intrathoracic LNs;
- Operating physician considered EBUS-TBNA should be performed on LNs for diagnosis or preoperative staging of lung cancer;
- Patients agree to undergo EBUS-TBNA, sign informed consent, and have no contraindications.
Exclusion
- \- Patients having other situations that are not suitable for EBUS-TBNA.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT04328792
Start Date
July 1 2018
End Date
December 31 2020
Last Update
April 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China, 200030